Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$710.94 USD

710.94
827,439

+12.14 (1.74%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $710.01 -0.93 (-0.13%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (46 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Retain Stryker Stock Right Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.

Zacks Equity Research

NextGen (NXGN) Solutions Support COVID-19 Vaccine Distribution

by Zacks Equity Research

NextGen (NXGN) lends a hand to the nationwide rollout of COVID-19 vaccines through its robust EHR platform and integrated solutions.

Zacks Equity Research

Should Value Investors Buy McKesson (MCK) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

MCK vs. WST: Which Stock Is the Better Value Option?

by Zacks Equity Research

MCK vs. WST: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why You Should Hold on to McKesson (MCK) Stock Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

Zacks Equity Research

Should Value Investors Choose McKesson Corp (MCK) Stock?

by Zacks Equity Research

Let's see if McKesson Corp (MCK) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Equity Research

Why Is McKesson (MCK) Up 8.9% Since Last Earnings Report?

by Zacks Equity Research

McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Here's Why You Should Retain McKesson (MCK) Stock for Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

Zacks Equity Research

Company News for Nov 4, 2020

by Zacks Equity Research

Companies In The News Are: W, HUM, MCK, CRUS

Zacks Equity Research

McKesson (MCK) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

McKesson's (MCK) fiscal second-quarter 2021 results benefit from strong segmental performance.

Zacks Equity Research

McKesson (MCK) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

McKesson (MCK) delivered earnings and revenue surprises of 24.03% and 2.50%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

McKesson (MCK) to Post Q2 Earnings: What's in the Offing?

by Zacks Equity Research

McKesson's (MCK) fiscal second-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.

Trina Mukherjee headshot

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

by Trina Mukherjee

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. CAH, WST and MCK are well positioned to gain from the prospects.

Zacks Equity Research

MCK or WST: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MCK vs. WST: Which Stock Is the Better Value Option?

Trina Mukherjee headshot

Dental Market Picks Up Pace Amid COVID-19: 3 Stocks to Watch

by Trina Mukherjee

Let's keep a watch on potentially strong three stocks in the dental space that have shown promise during the pandemic.

Zacks Equity Research

Nevro Bolsters Growth Prospects With New Manufacturing Plan

by Zacks Equity Research

Nevro (NVRO) commences plan for manufacturing operations in Costa Rica, thereby expanding its geographic footprint and boosting growth prospects.

Zacks Equity Research

Here's Why You Should Retain McKesson (MCK) Stock for Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

Zacks Equity Research

McKesson (MCK) Down 4.3% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

McKesson Extends Partnership With CDC to Fight Coronavirus

by Zacks Equity Research

McKesson (MCK) extends partnership with the CDC to aid in the distribution of future COVID-19 vaccines.

Zacks Equity Research

Company News for Aug 4, 2020

by Zacks Equity Research

Companies In The News Are: TSN, MCK, MCY, TKR.

Zacks Equity Research

McKesson (MCK) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

McKesson's (MCK) fiscal first-quarter 2021 results benefit from strong U.S. Pharmaceutical and Specialty Solutions segment.

Zacks Equity Research

McKesson (MCK) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

McKesson (MCK) delivered earnings and revenue surprises of 17.87% and 3.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

McKesson (MCK) to Post Q1 Earnings: What's in the Offing?

by Zacks Equity Research

McKesson's (MCK) fiscal first-quarter results are likely to reflect solid show by U.S. Pharmaceutical and Specialty Solutions segment.

Zacks Equity Research

Earnings Preview: McKesson (MCK) Q1 Earnings Expected to Decline

by Zacks Equity Research

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here's Why You Should Retain McKesson (MCK) Stock for Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.